The case underscores a key issue clinicians are seeing more often: differentiating GLP-1 related gastrointestinal intolerance from cannabis hyperemesis syndrome, especially in medically complex patients
Moreover, the growing physician preference for treatments that offer both metabolic and cardiovascular benefits, growing emphasis on preventive cardiology, and expanding guidelines supporting the use of these therapies in high-risk cardiovascular patients are all factors driving segment growth
Thus, the potential positive effect of DPP-4 inhibitors on osteoporosis and fractures may be more apparent in postmenopausal women because of higher bone remodeling
Understanding these predispositions can support a more informed conversation with your provider about whether a prescription-based or lifestyle-first approachor a combinationaligns with your biology and treatment readiness
Additionally, those seeking alternatives to conventional sedative-hypnotics due to tolerance, dependency, or adverse side effects could be potential candidates
PlexusDx flat-rate pricing means your dose may increase during titration, but your price won't changeyou pay $189/month whether you're at 0.25 mg or 2.4 mg weekly
